The Heath, Labor and Welfare ministry says a publisher passed off advertorials as articles.
For women suffering from breast cancer, online tools appeared to be helpful in battling depression, a randomized trial showed.
The months-old app seeks to become an all-in-one HCP tool and work on a 3.0 version is already in place.
CMI/Compas says mobile-ad recall is low but growing, and that smartphones rule professional mobile use.
Publisher middleman DeepDyve has launched a five-minute "freemium" service that CEO William Park says saves researchers money, and prevents the hassle of buying off-target research. Publishers such as Wiley support the service through cross-promotions on their websites.
A cocktail of older meds works as well as Enbrel, a study found, but docs are already comfortable with prescribing the biologic and aren't likely to switch therapies.
The aggregation tool builds out Lilly's roster of research apps.
JAMA's look into the impact of patient centric care shows that a broader scope is needed to understand the financial and health impact of active patients and how doctors perceive what it means to be engaged with patients.
Pharmas are spending far less on reprints and far more on digital promotion to physicians and other healthcare professionals, according to a healthcare media buying specialist.
Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.